For the past 17 years, SG Analytics (SGA) has been assisting pharmaceutical, medical device, and life sciences companies internationally, helping them boost revenue and expand market share. Unlike many other research businesses, we prioritize the protection of your company's sensitive information. Our expertise in opportunity analysis and prioritization, market entrance evaluations, and competitive intelligence (CI) has been crucial to our expansion. Additionally, bespoke research and consultancy for evaluating potential market sizes and forecasts have played a significant role. Recognized as a leading market research services provider company globally for the healthcare... Read More
SGA has positioned itself as a foremost source for research and insights in the healthcare industry, employing qualified analysts supported by advanced technology and data analytics. We deliver unparalleled data metrics, insights, and recommendations within the specialized domains of the healthcare industry. To manage information access, we leverage the Amazon Web Services (AWS) platform for data administration. Additionally, based on project requirements, we may also access the client's server remotely through a virtual private network (VPN).
Our life sciences and healthcare research team works with customers to co-create strategic roadmaps, disseminate those plans to the appropriate stakeholders, and implement optimized go-to-market strategies.
Using artificial intelligence and machine learning techniques, SGA aids in evaluating new medicine or product value evidence for reimbursement and healthcare payers.
There is a potential M&A market of almost $500 billion. With our assistance, you may reduce the time it takes to go from the first search to releasing your product or service to the market.
Combining strategy and market evaluation with competitive analysis for healthcare and life sciences firms looking to introduce or improve sales, marketing, or product development in the face of price competition. It entails deciding whether or not to enter a market and whether or not to pursue specific prospects.
We aid in assessing the potential dangers of new entrants, keeping tabs on the existing industry's key players and technological developments, monitoring the market's health, the influence of suppliers and purchasers, and the accessibility of suitable alternatives and related markets.
Through our proprietary KOL panel, we can quickly and accurately identify, map, and engage healthcare's most influential thought leaders.
Customers' needs in terms of targeting, customer segmentation that may be implemented for improved marketing and sales results, purchasing patterns, the influencers' roles, and product development or optimization decisions.
Why SGA
Industry Leaders
SGA thrives by its brand promise Lifes Possible and is recognized among the trusted life sciences & healthcare business consulting & services providers in the U.S.
12+ Languages
Multilingual capabilities include Mandarin, Cantonese, Korean, German, Spanish, Arabic, Bahasa, Hindi, Bengali, and English (U.S. & U.K.) experts (either in-house or partnerships).
Data-Driven Insights
With in-depth domain knowledge and proven capabilities of delivering monetizable insights, we deliver high-quality, efficient outputs.
End-To-End Solutioning
The in-house KOL capability of more than 700, along with in-house capabilities of primary market research, financial research, data analytics, engineering, IT, and ESG research and consulting, helps to present credible competitive information.
White Papers
Emergence of Novel Immune - Mediated Therapies
Immunotherapy has emerged as a promising treatment for cancer, with immune checkpoint inhibitors (ICIs) dominating the market. The market is projected to...
White Papers
Future Trends and Technological Advances in Vaccine and...
The introduction of vaccines for key diseases, such as meningococcal meningitis A, hepatitis E, and malaria, in recent years has helped to reduce mortality...
CASE STUDIES
